{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:18:49Z","timestamp":1770833929314,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.pharep.2018.10.010","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T14:29:08Z","timestamp":1540304948000},"page":"225-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The muscarinic antagonist gallamine induces proliferation of airway smooth muscle cells regardless of the cell phenotype"],"prefix":"10.1007","volume":"71","author":[{"given":"Rodopi","family":"Stamatiou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1312-0322","authenticated-orcid":false,"given":"Efrosini","family":"Paraskeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Vasilaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolia","family":"Hatziefthimiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"4","key":"10.1016\/j.pharep.2018.10.010_bib0005","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1513\/pats.200802-014ET","article-title":"New concept in the pathobiology of chronic obstructive pulmonary disease","volume":"5","author":"Kim","year":"2008","journal-title":"Proc Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.pharep.2018.10.010_bib0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1513\/pats.200705-063VS","article-title":"Airway smooth muscle growth in asthma","volume":"5","author":"Bentley","year":"2008","journal-title":"Proc Am Thorac Soc"},{"issue":"3 Suppl","key":"10.1016\/j.pharep.2018.10.010_bib0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1378\/chest.123.3_suppl.417S","article-title":"Airway remodeling in asthma","volume":"123","author":"Vignola","year":"2003","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.pharep.2018.10.010_bib0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1164\/ajrccm.164.supplement_2.2106061","article-title":"Remodelling in asthma and chronic obstructive lung disease","volume":"164","author":"Jeffery","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.pharep.2018.10.010_bib0025","first-page":"65","article-title":"Phosphatidylinositol 3 \u2013kinase mediates mitogen-induced human airway smooth muscle cell proliferation","volume":"277","author":"Krymskaya","year":"1999","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.pharep.2018.10.010_bib0030","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1183\/09031936.93.06030328","article-title":"Muscarinic receptors sybtypes in airways","volume":"6","author":"Barnes","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharep.2018.10.010_bib0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2466-14-39","article-title":"Long-term exposure to muscarinic agonists decreases expression of contractile proteins and responsiveness of rabbit tracheal smooth muscle cells","volume":"14","author":"Stamatiou","year":"2014","journal-title":"BMC Pulm Med"},{"issue":"2\u20133","key":"10.1016\/j.pharep.2018.10.010_bib0040","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-2999(93)90062-M","article-title":"The interaction of selective and non-selective antagonists with pre- and post-junctional muscarinic receptor subtypes in guinea pig trachea","volume":"233","author":"Ten Berge","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.10.010_bib0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1165\/ajrcmb\/9.5.541","article-title":"Expression of muscarinic M2 receptors in cultured human airway smooth muscle cells","volume":"9","author":"Widdop","year":"1993","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharep.2018.10.010_bib0050","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1165\/ajrcmb\/7.3.344","article-title":"Localization of muscarinic receptor subtype mRNAs in human lung","volume":"7","author":"Mak","year":"1992","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharep.2018.10.010_bib0055","doi-asserted-by":"crossref","first-page":"L1163","DOI":"10.1152\/ajplung.00471.2006","article-title":"p42\/p44 MAP kinase activation is localized to caveolae-free membrane domains in airway smooth muscle","volume":"292","author":"Gosens","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharep.2018.10.010_bib0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1465-9921-7-73","article-title":"Muscarinic receptor signaling in the pathophysiology of asthma and COPD","volume":"7","author":"Gosens","year":"2006","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.pharep.2018.10.010_bib0065","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/pupt.2001.0313","article-title":"The non-neuronal cholinergic system: an emerging drug target in the airways","volume":"14","author":"Wessler","year":"2001","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharep.2018.10.010_bib0070","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1183\/09031936.00112412","article-title":"Muscarinic receptor subtype-specific effects on cigarette smoke-induced inflammation in mice","volume":"42","author":"Kistemaker","year":"2013","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.pharep.2018.10.010_bib0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0163-7258(03)00004-4","article-title":"Muscarinic acetylcholine receptors and airway diseases","volume":"98","author":"Coulson","year":"2003","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pharep.2018.10.010_bib0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1939-4551-6-22","article-title":"M2 Muscarinic acetylcholine receptor modulates rat airway smooth muscle cell proliferation","volume":"6","author":"Placeres-Uray","year":"2013","journal-title":"World Allergy Organ J"},{"issue":"4","key":"10.1016\/j.pharep.2018.10.010_bib0085","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00151829-200403040-00005","article-title":"Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD","volume":"3","author":"Keam","year":"2004","journal-title":"Treat Respir Med"},{"issue":"12","key":"10.1016\/j.pharep.2018.10.010_bib0090","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s11882-014-0484-y","article-title":"Anticholinergics\/antimuscarinic drugs in asthma","volume":"14","author":"Soler","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"10.1016\/j.pharep.2018.10.010_bib0095","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0014-5793(95)01360-1","article-title":"Constitutive activity of the M1-M4 subtypes of muscarinic receptors in transfected CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists","volume":"377","author":"Jakub\u00edk","year":"1995","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.pharep.2018.10.010_bib0100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/med.20166","article-title":"Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities","volume":"30","author":"De Amici","year":"2010","journal-title":"Med Res Rev"},{"issue":"3","key":"10.1016\/j.pharep.2018.10.010_bib0105","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1183\/09031936.00089407","article-title":"Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells","volume":"34","author":"Stamatiou","year":"2009","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.pharep.2018.10.010_bib0110","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.steroids.2010.12.010","article-title":"The mitogenic effect of testosterone and 17\u03b2-estradiol on airway smooth muscle cells","volume":"76","author":"Stamatiou","year":"2011","journal-title":"Steroids"},{"issue":"16","key":"10.1016\/j.pharep.2018.10.010_bib0115","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.1073\/pnas.93.16.8705","article-title":"Activation of muscarinic acetylcholine receptors via their allosteric binding sites","volume":"93","author":"Jakub\u00edk","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.pharep.2018.10.010_bib0120","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/jpet.104.073767","article-title":"Regulation of M2 muscarinic acetylcholine receptor expression and signaling by prolonged exposure to allosteric modulators","volume":"312","author":"May","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2018.10.010_bib0125","first-page":"18","article-title":"Selective muscarinic receptor antagonists","author":"Hammer","year":"1984","journal-title":"TIPS"},{"issue":"1","key":"10.1016\/j.pharep.2018.10.010_bib0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0922-4106(89)90045-X","article-title":"Allosteric interactions of three muscarine antagonists at bovine tracheal smooth muscle and cardiac M2 receptors","volume":"172","author":"Roffel","year":"1989","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2018.10.010_bib0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2680.2000.00163.x","article-title":"Probing the selectivity of allosteric modulators of muscarinic receptors at other G-protein-coupled receptors","volume":"20","author":"Pfaffendorf","year":"2000","journal-title":"J Auton Pharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2018.10.010_bib0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002109900176","article-title":"Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors","volume":"361","author":"Franken","year":"2000","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2018.10.010_bib0145","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/mol.105.017814","article-title":"Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonist","volume":"69","author":"Langmead","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharep.2018.10.010_bib0150","first-page":"409","article-title":"Muscarinic receptors and their antagonists in COPD: anti-inflammatory and antiremodeling effects","author":"Karakiulakis","year":"2012","journal-title":"Mediators Inflamm"},{"issue":"6","key":"10.1016\/j.pharep.2018.10.010_bib0155","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/sj.bjp.0703931","article-title":"Dual effects of muscarinic M2 acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists","volume":"132","author":"Michal","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2018.10.010_bib0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pupt.2012.05.007","article-title":"cAMP regulation of airway smooth muscle function","volume":"26","author":"Billington","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"issue":"5\u20136","key":"10.1016\/j.pharep.2018.10.010_bib0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/10799899009064668","article-title":"Muscarinic receptor expression in the primary culture of tracheal smooth muscle cells","volume":"10","author":"Yang","year":"1990","journal-title":"J Recept Res"},{"issue":"7","key":"10.1016\/j.pharep.2018.10.010_bib0170","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/sj.bjp.0705178","article-title":"Evidence for cross-talk between M2 and M3 muscarinic acetylcholine receptors in the regulation of second messenger and extracellular signal-regulated kinase signalling pathways in Chinese hamster ovary cells","volume":"138","author":"Hornigold","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharep.2018.10.010_bib0175","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jcp.21450","article-title":"Dual ERK and phosphatidylinositol 3-kinase pathways control airway smooth muscle proliferation: differences in asthma","volume":"216","author":"Burgess","year":"2008","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.pharep.2018.10.010_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0703311","article-title":"Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery","volume":"130","author":"de Ligt","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharep.2018.10.010_bib0185","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bcp.2004.04.016","article-title":"Cyclic nucleotide-dependent phosphodiesterases (PDEI) inhibition by muscarinic antagonists in bovine tracheal smooth muscle","volume":"68","author":"Guerra de Gonz\u00e1lez","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.pharep.2018.10.010_bib0190","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/dneu.20976","article-title":"Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation","volume":"72","author":"De Angelis","year":"2012","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.pharep.2018.10.010_bib0195","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.intimp.2018.01.006","article-title":"Cholinergic regulation of proliferation of the urothelium in response to E. coli lipopolysaccharide exposition","volume":"56","author":"Podmol\u00edkov\u00e1","year":"2018","journal-title":"Int Immunopharmacol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017307636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017307636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:48Z","timestamp":1752611868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2018.10.010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1734114017307636"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2018.10.010","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The muscarinic antagonist gallamine induces proliferation of airway smooth muscle cells regardless of the cell phenotype","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2018.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}